Pharmacotherapy review: angiotensin-converting enzyme inhibitors.

Abstract

On inspection of most treatment algorithms for hypertension, it is apparent that multiple drug classes are available. In choosing a medication class for hypertension therapy, nuances of the selection process often go unappreciated. This article is the first in a series describing important pharmacotherapeutic considerations of the individual drug classes used in the treatment of hypertension.